TARDBP and neurodegenerative disease: The results from their analyses show that RBP module alterations seen in AD are also seen in frontotemporal lobar degeneration with TDP-43 pathology—a subtype of FTD that, contrary to other FTD subtypes, is characterized by the presence of TARDBP inclusions and the absence of Tau pathology [32]— and corticobasal degeneration (CBD), but not in other neurodegenerative diseases such as ALS, progressive supranuclear palsy, multiple systems atrophy, or Parkinson’s disease (PD).